Vanessa Cerisano
About
In The Last Decade
Vanessa Cerisano
11 papers receiving 723 citations
Peers
Comparison fields: 5 of 58
- Molecular Biology 396
- Pulmonary and Respiratory Medicine 318
- Oncology 183
- Cancer Research 163
- Endocrinology, Diabetes and Metabolism 137
Countries citing papers authored by Vanessa Cerisano
This map shows the geographic impact of Vanessa Cerisano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Cerisano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Cerisano more than expected).
Fields of papers citing papers by Vanessa Cerisano
This network shows the impact of papers produced by Vanessa Cerisano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Cerisano. The network helps show where Vanessa Cerisano may publish in the future.
Co-authorship network of co-authors of Vanessa Cerisano
This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Cerisano. A scholar is included among the top collaborators of Vanessa Cerisano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Cerisano. Vanessa Cerisano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 94 | |
| 2 | 53 | |
| 3 | 73 | |
| 4 | 94 | |
| 5 | 85 | |
| 6 | 89 | |
| 7 | Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells. | 43 |
| 8 | Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells. | 114 |
| 9 | 12 | |
| 10 | 14 | |
| 11 | CD99 engagement: an effective therapeutic strategy for Ewing tumors. | 79 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.